Topic: Medicaid

Three drugmakers post improved 1st-quarter profits and sales, rest of year looks less rosyThree top drugmakers on Thursday posted healthy increases in first-quarter sales and profits, with strong sales of key drugs buoying Bristol-Myers Squibb Co., AstraZeneca LP and Sanofi-Aventis SA. Their ...
The drugmaker Merck & Co. said Friday the federal health care overhaul will reduce its revenue by about $170 million this year and by roughly double that amount next year — less than the impact some rivals have reported. Its shares rose ...
GOOD NEWS, BAD NEWS: Amgen Inc.'s first-quarter profit beat Wall Street expectations as sales of its anti-infection drugs improved. However the company said 2010 results will come in at the low end of its forecast due to health reform costs. DISCOUNTS: Amgen ...
German drugmaker, state of Wisconsin reach $7.75M settlement on suit alleging Medicaid fraudA German-based pharmaceutical company has agreed to pay $7.75 million to settle allegations that four of its subsidiaries committed price fraud, Wisconsin Attorney General J.B. Van Hollen said Tuesday. The ...
THE INFLUENCE GAME: Lobbying pays off as drug industry hits jackpot with health overhaul.Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's health care law even as it ...
NJ drug company agrees to pay $3.5 settlement with federal authoritiesFederal prosecutors say a New Jersey pharmaceutical company has agreed to pay $3.5 million to settle allegations that it claimed its heart drug was eligible for Medicaid reimbursement. The U.S. attorney's office ...
15 states sue Amgen, alleging kickback scheme to boost sales of anemia drug AranespBiotechnology behemoth Amgen Inc. is being sued by 15 states alleging the company gave kickbacks to medical providers to help boost sales of the anemia drug Aranesp. The New ...
Wyoming to collect nearly $50,000 from 4 pharmaceutical companies for alleged Medicaid fraudFour pharmaceutical companies have reached a nearly $50,000 settlement with the state of Wyoming for allegedly submitting false claims to the Medicaid program. Wyoming Attorney General Bruce Salzburg says the ...
Mylan Inc. and two other drugmakers will pay $124 million to settle claims they did not properly reimburse Medicaid for drugs, officials said Monday. New York Attorney General Andrew Cuomo said two Mylan subsidiaries, along with one division of AstraZeneca PLC and ...
The Alabama Supreme Court on Friday threw out jury decisions awarding the state more than $274 million from three pharmaceutical companies, ruling they did not defraud the state in pricing Medicaid prescription drugs. The court overturned jury verdicts against the drug companies ...
Previous